Amid evidence that Johnson & Johnson continued to sell a dangerous vaginal mesh implant for nine months after the U.S. Food and Drug Administration ordered it to stop, some observers are questioning whether federal regulatory agencies are currently able protect consumers.
A Bloomberg story quotes University of Michigan business professor Erik Gordon as saying that the issue points out “the industry’s ability to shrug off FDA enforcement. If companies can get ...
continue reading...